Back

prof. dr. M. (Miriam) Koopman

prof. dr. M. (Miriam) Koopman

Full Professor

Show full profile

Research Output (219)

Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer

Franken M. D., van Rooijen E. M., May A. M., Koffijberg H., van Tinteren H., Mol L., ten Tije A. J., Creemers G. J., van der Velden A. M. T., Tanis B. C., Groot C. A. Uyl-de, Punt C. J. A., Koopman M., van Oijen M. G. H. Apr 2017, In: European Journal of Cancer. 75 , p. 204-212 9 p.

From tumour heterogeneity to advances in precision treatment of colorectal cancer

Punt Cornelis J. A., Koopman Miriam, Vermeulen Louis Apr 2017, In: Nature Reviews Clinical Oncology. 14 , p. 235-246 12 p.

Prognostic Relevance of Palliative Primary Tumor Removal:Why Randomized Controlled Data Are Still Mandatory

Tlam-Boer Jorine, De Wilt Hans, Koopman Miriam Apr 2017, In: Annals of Surgery. 265 , p. e58-e59

Mortality reduction by post-dilution online-haemodiafiltration:A cause-specific analysis

Nubé Menso J. et al. Mar 2017, In: Nephrology Dialysis Transplantation. 32 , p. 548-555 8 p.

Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry

Trinh Anne, Trumpi Kari, De Sousa E Melo Felipe, Wang Xin, De Jong Joan H., Fessler Evelyn, Kuppen Peter J K, Reimers Marlies S., Swets Marloes, Koopman Miriam, Nagtegaal Iris D., Jansen Marnix, Hooijer Gerrit K J, Offerhaus George J A, Kranenburg Onno, Punt Cornelis J., Medema Jan Paul, Markowetz Florian, Vermeulen Louis 15 Jan 2017, In: Clinical Cancer Research. 23 , p. 387-398 12 p.

Incidence of capecitabine-related cardiotoxicity in different treatment schedules of metastatic colorectal cancer:A retrospective analysis of the CAIRO studies of the Dutch Colorectal Cancer Group

Kwakman Johannes J M, Simkens Lieke H J, Mol Linda, Kok Wouter E M, Koopman Miriam, Punt Cornelis J A 2017, In: European Journal of Cancer. 76 , p. 93-99 7 p.

Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands:A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group

Keikes Lotte, van Oijen Martijn G.H., Lemmens Valery E. P. P., Koopman Miriam, Punt Cornelis J A 2017, In: Clinical colorectal cancer. 17 , p. 58-64 7 p.

Chromosome 18q11.2 loss as a predictive marker for response to bevacizumab in metastatic colorectal cancer

Ylstra B., Cordes M., Biesma H. D., Verheul H. M., Neerincx M., Koopman M., Punt C. J., Meijers G. A., Murphy V., Barat A., Betge J., Ebert M., Gaiser T., Fender B., Klinger R., Das S., Smeets D., Lambrechts D., Byrne A. T., Van Grieken N. C. T. Dec 2016, In: European Journal of Cancer. 68 , p. S29-S29

Yttrium-90 radioembolization for colorectal cancer liver metastases:a prospective cohort study on circulating angiogenic factors and treatment response

Rosenbaum C E N M, van den Hoven A F, Braat M N G J A, Koopman M, Lam M G E H, Zonnenberg B A, Verkooijen H M, van den Bosch Maurice Dec 2016, In: EJNMMI physics. 6

Significant increase of synchronous disease in first-line metastatic colorectal cancer trials:Results of a systematic review

Goey Kaitlyn K H, 't Lam-Boer Jorine, de Wilt Johannes H W, Punt Cornelis J A, van Oijen Martijn G H, Koopman Miriam 4 Nov 2016, In: European Journal of Cancer. 69 , p. 166-177 12 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not